Re: Restaging Transurethral Resection of High Risk Superficial Bladder Cancer Improves the Initial Response to Bacillus Calmette-Guerin Therapy. H. W. Herr J Urol, 174: 2134-2137, 2005

Journal of Urology

Volumn 176, Issue 1, 2006, Pages 407-408

  Palou, J ^a   Rodriguez O ^a   Segarra, J ^a   Rosales, A ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BLADDER CANCER; CANCER RESEARCH; CANCER RISK; CANCER STAGING; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSURETHRAL RESECTION;

ADJUVANTS, IMMUNOLOGIC; BCG VACCINE; COMBINED MODALITY THERAPY; CYSTECTOMY; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; REOPERATION; URINARY BLADDER NEOPLASMS;

EID: 33744534507     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(06)00593-3     Document Type: Letter

References (5)

1. Klan R., Loy V., and Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146 (1991) 316
2. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74
3. Kolozsy Z. Histopathological "self control" in transurethral resection of bladder tumours. Br J Urol 67 (1991) 162
4. Pieras Ayala E., Palou J., Rodriguez-Villamil L., Millan Rodriguez F., Salvador Bayarri J., and Vicente Rodriguez J. Cytoscopic follow-up of initial G3T1 bladder tumors treated with BCG. Arch Esp Urol 54 (2001) 211
5. Millan-Rodriguez F., Palou J., Chechile-Toniolo G., Montlleo-Gonzalez M., Huguet-Perez J., and Salvador-Bayarri J. Re. The value of a second transurethral resection in evaluating patients with bladder tumors [letter to the editor]. J Urol 163 (2000) 1258